In the present study, we analyzed PON2 protein expression by immunohistochemistry using ovarian cancer tissue arrays containing stage I (n = 23), stage II (n = 20), stage III (n = 35), stage IV (n = 12), metastasis (n = 10), and control (n = 20) tissues. The gene discussed is PON2; the disease is ovarian carcinoma.